After a two-day meeting in Geneva, Switzerland, the World Health Organisation (WHO) recommended extra safety precautions for Sanofi’s dengue fever vaccine, Dengvaxia. WHO said on Thursday that the vaccine should
After a two-day meeting in Geneva, Switzerland, the World Health Organisation (WHO) recommended extra safety precautions for Sanofi’s dengue fever vaccine, Dengvaxia. WHO said on Thursday that the vaccine should